A 51-year-old man with chronic HIV and opioid use disorder is referred to a methadone clinic to start methadone maintenance therapy. He is taking dolutegravir plus tenofovir alafenamide-emtricitabine and trazodone (for insomnia).
If opioid use disorder therapy with methadone is initiated, which one of the following would be a concerning potential adverse effect?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
October 1st, 2023
October 1st, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5